High-purity spent solvents from pharma synthesis are premium feedstocks for solvent recovery operations. SymbioFlows identifies every valorization route for your waste portfolio.
Get Your Valorization Report~200k t/yr
Pharma solvent consumption (EU)
src: CEFIC est.
70–90%
Solvent recovery potential
src: SOCMA 2021
€200–600/t
Solvent incineration vs recovery saving
src: industry avg
18–28 MJ/kg
API distillation residue calorific value
src: process data
| EWC Code | Material | Who Buys It |
|---|---|---|
| 07 05 04* | Halogenated Spent Solvents | Solvent re-distillers, cement kiln co-processing |
| 07 05 03* | Non-halogenated Spent Solvents | Solvent recovery distillers — high return value for pure streams |
| 07 05 08* | API Distillation Residues | High-temperature incineration, cement kiln co-processing |
| 07 05 14* | Solid Waste from API Processes | Hazardous waste incineration |
| 15 01 10* | Contaminated Packaging | Industrial drum reconditioning, hazardous waste |
* hazardous under EU Waste Framework Directive 2008/98/EC
Waste-stream pages and resources connected to Pharmaceutical.
Your complimentary report grades recovery potential across your solvent and co-processing streams.
Request Your Valorization ReportLearn about the financial and environmental benefits of industrial symbiosis